Roberto Caporali to Drug Substitution
This is a "connection" page, showing publications Roberto Caporali has written about Drug Substitution.
Connection Strength
0.537
-
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry. Int J Rheum Dis. 2018 Feb; 21(2):422-430.
Score: 0.537